| Sep 16 |
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
|
| Sep 12 |
Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?
|
| Sep 11 |
Liquidia to Raise $67.5 Million From Public Offering, Private Placement of Shares
|
| Sep 11 |
Liquidia stock rises after it prices public and private offering
|
| Sep 11 |
Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
|
| Aug 28 |
Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity
|
| Aug 28 |
Liquidia to Present at Upcoming Investor Conferences
|
| Aug 26 |
Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’
|
| Aug 22 |
Liquidia challenges exclusivity blocking Yutrepia in new lawsuit
|
| Aug 22 |
Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD
|
